These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 36113962)

  • 1. Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort.
    Truchetet ME; Drumez E; Barnetche T; Martin C; Devaux M; Goulenok T; Maria A; Schmidt J; Abdallah NA; Melki I; Hachulla E; Richez C
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36113962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
    FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors
    Ann Rheum Dis; 2021 Apr; 80(4):527-538. PubMed ID: 33268442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.
    Avouac J; Drumez E; Hachulla E; Seror R; Georgin-Lavialle S; El Mahou S; Pertuiset E; Pham T; Marotte H; Servettaz A; Domont F; Chazerain P; Devaux M; Claudepierre P; Langlois V; Mekinian A; Maria ATJ; Banneville B; Fautrel B; Pouchot J; Thomas T; Flipo RM; Richez C; ;
    Lancet Rheumatol; 2021 Jun; 3(6):e419-e426. PubMed ID: 33786454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.
    Bourguiba R; Kyheng M; Koné-Paut I; Rouzaud D; Avouac J; Devaux M; Abdallah NA; Fautrel B; Ferreira-Maldent N; Langlois V; Ledoult E; Nielly H; Queyrel V; Sellam J; Tieulie N; Chazerain P; Evon P; Labreuche J; Savey L; Hentgen V; Grateau G; Georgin-Lavialle S;
    RMD Open; 2022 May; 8(1):. PubMed ID: 35537796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection.
    Comarmond C; Drumez E; Labreuche J; Hachulla E; Thomas T; Flipo RM; Seror R; Avouac J; Balandraud N; Desbarbieux R; Felten R; Gilson M; Guyot MH; Hittinger-Roux A; Pham T; Renard M; Roux N; Sobanski V; Tournadre A; Richez C; Cacoub P;
    J Transl Autoimmun; 2023; 6():100190. PubMed ID: 36684808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort.
    Perrot L; Boyer L; Flipo RM; Marotte H; Pertuiset E; Miceli C; Thomas T; Seror R; Chazerain P; Roux N; Richez C; Pham T;
    Joint Bone Spine; 2023 Dec; 90(6):105608. PubMed ID: 37414137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equated hospitalization rate of patients with inflammatory rheumatic diseases as compared to normal population in 2°wave SARSCoV2 infection.
    Dallagiacoma G; Weichenberger CX; Raffainer B; Callegher SZ; Matzneller P; Hantikainen E; Domingues FS; Karadar L; Kuppelwieser I; Masl A; Mian M; Maier A; Dejaco C
    Rheumatology (Oxford); 2023 Dec; ():. PubMed ID: 38059600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.
    Neuberger M; Sommerer C; Böhnisch S; Metzendorf N; Mehrabi A; Stremmel W; Gotthardt D; Zeier M; Weiss KH; Rupp C
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):543-550. PubMed ID: 31924555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
    Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry.
    Doria C; Greenstein S; Narayanan M; Ueda K; Wiland A; McCague K; Sankari B; Chan L
    Clin Transplant; 2012; 26(6):E602-11. PubMed ID: 23121178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.
    Cordtz R; Lindhardsen J; Soussi BG; Vela J; Uhrenholt L; Westermann R; Kristensen S; Nielsen H; Torp-Pedersen C; Dreyer L
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI59-SI67. PubMed ID: 33369663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting therapy response to mycophenolic acid using UGT1A9 genotyping: towards personalized medicine in atopic dermatitis.
    Thijs JL; Van Der Geest BAM; Van Der Schaft J; Van Den Broek MP; Van Seggelen WO; Bruijnzeel-Koomen CAF; Hijnen DJ; Van Schaik RH; De Bruin-Weller MS
    J Dermatolog Treat; 2017 May; 28(3):242-245. PubMed ID: 27549213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum albumin level is associated with mycophenolic acid concentration in children with idiopathic nephrotic syndrome.
    Nishimura T; Uemura O; Hibino S; Tanaka K; Kitagata R; Yuzawa S; Kasagi T; Fujita N
    Eur J Pediatr; 2022 Mar; 181(3):1159-1165. PubMed ID: 34779909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the proton-pump Inhibitor pantoprazole on MycoPhenolic ACid exposure in kidney and liver transplant recipienTs (IMPACT study): a randomized trial.
    Sunderland A; Russ G; Sallustio B; Cervelli M; Joyce D; Ooi E; Jeffrey G; Boudville N; Chakera A; Dogra G; Chan D; Wong G; Lim WH
    Nephrol Dial Transplant; 2020 Jun; 35(6):1060-1070. PubMed ID: 32516810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre cohort study of acute cholecystitis management during the COVID-19 pandemic.
    Martínez Caballero J; González González L; Rodríguez Cuéllar E; Ferrero Herrero E; Pérez Algar C; Vaello Jodra V; Pérez Díaz MD; Dziakova J; San Román Romanillos R; Di Martino M; de la Hoz Rodríguez Á; Galán Martín M; Sánchez López D; García Virosta M; de la Fuente Bartolomé M; Pardo de Lama MM; Gutiérrez Samaniego M; Díaz Pérez D; Alias Jiménez D; de Nicolás Navas L; Pérez Alegre JJ; García-Quijada García J; Guevara-Martínez J; Villadoniga A; Martínez Fernández R
    Eur J Trauma Emerg Surg; 2021 Jun; 47(3):683-692. PubMed ID: 33742223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.
    van Gelder T; Silva HT; de Fijter H; Budde K; Kuypers D; Mamelok RD; Armstrong VW; Oellerich M
    Ther Drug Monit; 2011 Apr; 33(2):155-64. PubMed ID: 21383657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study.
    Fredi M; Cavazzana I; Moschetti L; Andreoli L; Franceschini F;
    Lancet Rheumatol; 2020 Sep; 2(9):e549-e556. PubMed ID: 32838307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
    Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
    Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.